info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)

Asia Pacific Skin Cancer: Increasing Demand For The Better Treatment of The Cancer is Projected to Uplift The Market at a CAGR of 7.80% During The Forecasted Period 2022-2030

Pune, India, December 2022/MRFR Press Release/- Market Research Future has a half cooked research report on the Asia Pacific skin cancer market.


Market Highlights


Cancer is becoming one of the major problems across the globe. Different types of cancer are been registered around the globe, but skin cancer is considered as one of the most common types of cancer. Over 90% of skin cancer caused due to exposure to ultraviolet radiation from the sun. These ultraviolet radiations are increasing continuously due to reducing ozone level.


There are three major types of skin cancer namely basal cell skin cancer (BCC), squamous-cell skin cancer (SCC) and melanoma. Exposure to the radiation during childhood can cause melanomas and basal-cell cancers. People with light skin are more susceptible to the skin cancer.


The Asia Pacific skin cancer market is driven by increasing prevalence of skin cancer, the presence of developing economies and increasing government support. Australia accounts for the largest market share owing to a huge number of a patient having skin cancer. While adverse effect associated with the treatment, long approval time for the drugs, and strict regulatory policies may restrain the growth of the market over the corresponding period.


The Asia Pacific Skin Cancer Market is expected to reach USD 602.4 Million by 2030 at 7.80% CAGR during the forecast period 2022-2030


Regional Analysis


Australia dominates the Asia Pacific skin cancer market owing to exposure to UV radiation in sunlight, extensive use of commercial solariums, believe in tanning skin. According to Cancer Council Australia, Approximately, two in three Australians are likely to diagnose with skin cancer by the time they are 70 years old. Additionally above 750,000 people treated with skin cancer every year.


Japan accounts for the second largest market, where 20-25 cases of every 100,000 people are diagnosed with skin cancer. China is the third largest market due to huge population base, rapidly changing the economy, and increasing healthcare expenditure. The incidence of skin cancer in China per 100,000 population is 11-12 cases.


Countries like India, Republic of Korea, and rest of the Asia Pacific also showing significant growth in the skin cancer cases owing to increasing ultraviolet radiation from the sun.


Segmentation


Asia Pacific skin cancer market is segmented on the basis of type, by treatment, and by end users. On the basis of the type, it is segmented into basal cell carcinoma, squamous-cell carcinoma, and melanoma. On the basis of the treatment, it is segmented into non-invasive, chemotherapy, surgical, and other. Furthermore, non-invasive treatments are segmented into laser therapy, radiotherapy, photodynamic therapy, cryotherapy, and others, chemotherapy is segmented into systemic and targeted, and Surgical treatment are segmented into photodynamic therapy, cryosurgery, Mohs micrographic surgery, and others. On the basis of end users, the market is segmented into hospital and clinics, diagnostic centers, cancer research institute, and other.


Key Players


Some of key the players in the market are F. Hoffmann-la Roche Ltd. (Switzerland), Novartis International AG (Switzerland), Sun Pharma Industries Ltd. (India), Elekta AB (Sweden), Varian Medical Systems Inc. (US), Cannabis Science Inc. (US), Cellceutix Corp. (US), LEO Pharma A/S (Denmark), Moberg Pharma AB (Sweden), Mylan Pharmaceutical Inc. (US), Oncothyreon Inc. (US), Eli Lilly and Co. (US), Bristol Myers Squibb Co. (US), Boehringer Ingelheim GmbH (Germany), Aqua Pharmaceuticals LLC (US), Valeant Pharmaceuticals Inc (Canada), Meda AB (US), iCAD Inc. (Sweden), and Merck & Co. Inc. (US).


Browse In-depth Market Details [Table of Content, List of Figures, List of Tables] of Asia Pacific Skin Cancer Market Research Report

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Report details
Base Year 2022
Companies Covered 15
Pages 80
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.